RLMD Stock Analysis: Buy, Sell, or Hold?
RLMD - Relmada Therapeutics, Inc. Common Stock
$6.69
0.24 (3.72%)
▲
5d:
-0.59%
30d:
-7.85%
90d:
+2.45%
BUY
HIGH Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When RLMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RLMD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: RLMD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: RLMD is currently trading at $6.69, which is considered fair relative to its 30-day fair value range of $6.27 to $7.06.
Technical Outlook: Technically, RLMD is in a strong uptrend. Immediate support is located at $6.27, while resistance sits at $7.12. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: RLMD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.67 (+89.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RLMD is in a strong uptrend. Immediate support is located at $6.27, while resistance sits at $7.12. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: RLMD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $12.67 (+89.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$6.27 -
$7.06
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.7%)
- BULLISH: Trading 89.3% below Wall St target ($12.67)
Trading Range Analysis
30-Day Trading Range
$6.27 -
$7.06
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$6.27
Resistance Level
$7.12
Current Trend
Strong Uptrend
Technical data as of
Jun 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-16.32
Wall Street Target
$12.67
(+89.3%)
Share & Embed Analysis
Last updated: June 27, 2026 2:56 PM ET
Data refreshes hourly during market hours. Next update: 3:56 PM
Data refreshes hourly during market hours. Next update: 3:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 66 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 65 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 56 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 65 BUY |
